India pharma sees trouble for its industry in newly negotiated TPP Some say it may undermine sales of generics in the U.S. as well as in developing countries October 16, 2015 | By Eric Palmer

India is not part of the recently negotiated Trans-Pacific Partnership trade deal, but that doesn't mean the TPP won't still have a trade impact on its drug industry. As some industry veterans see it, the free-trade agreement spells bad news for the $15 billion drug industry that India has built by being a go-to country for cheap generic drugs.  http://www.fiercepharma.com/tags/india